Low fat diet can cut breast cancer risk

Image
IANS New York
Last Updated : Apr 16 2016 | 12:48 PM IST

A diet containing low-fat food items is likely to aid women in their postmenopausal phase to keep away from breast cancer as well as lower the mortality risk rates associated with the deadly disease, finds a study.

The findings showed that women who stayed on a low fat diet for approximately eight years reduced their risk of death from invasive breast cancers.

They also improved their survival rates by 82 percent when compared with women who had not followed the dietary regimen.

Women who did not follow the diet were at 78 percent overall survival risks.

"This was the first time we had examined the deaths after breast cancer among this group, and we found that a sustained low fat diet increased the survival rates among postmenopausal women after a breast cancer diagnosis," said Rowan Chlebowski from the Los Angeles Biomedical Research Institute in the US.

Also, heart disease mortality rate was seen to be lower in the dietary group.

However, most of the breast cancer characteristics -- including size, nodal status, and distribution of poor prognosis, triple negative cancers and HER2 positive cancers -- were found similar between the two groups of women.

"The study also suggests that women would need to remain on the low fat diets to maintain the benefits of the dietary intervention," Chlebowski suggested.

To determine the effects of a low fat dietary pattern on breast cancer, the team conducted additional analyses of a randomised clinical trial that had followed 48,835 postmenopausal women.

The women were aged 50-79, had no prior breast cancer and had normal mammograms as wells as had an intake normal dietary fat.

Of those, 19,541 women were put on a low fat diet with nutritionist-led group sessions that sought to reduce fat intake to 20 percent of energy and increase the consumption of fruits, vegetables and grain.

The other 29,294 women in the trial followed their usual dietary patterns.

The study was presented at a clinical trial plenary session, at the ongoing American Association for Cancer Research (AACR) annual meeting in Louisiana, US.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 16 2016 | 12:38 PM IST

Next Story